Non-contact Electric Field Exposure Provides Potential Cancer Therapy through p53-Independent Proliferation Arrest and Intrinsic Pathway Apoptosis Induction in MG-63 Cell Lines

Osteosarcoma, a highly malignant bone tumor primarily affecting children and young adults, poses significant challenges in treatment due to its aggressive nature and propensity for metastasis. Traditional therapies, including chemotherapy and surgery, often come with severe side effects and may not effectively halt the progression of the disease. This study explores a novel, non-invasive approach using non-contact electric field exposure as a potential therapy for osteosarcoma, focusing on its effects on MG-63 human osteosarcoma cells. The researchers exposed MG-63 cells to a non-contact electric field at a frequency of 200 kHz for six days. This treatment led to remarkable changes in cell behavior, including a significant reduction in cell proliferation and the induction of apoptosis. The study utilized real-time qPCR and flow cytometry to analyze gene expression and apoptotic indices, respectively.

Key Findings

1. Cell Morphology and Proliferation: Exposing MG-63 human osteosarcoma cells to a non-contact electric field at evidenced by dramatic changes in cell morphology. The treated cells at a frequency of 200 kHz for six days significantly reduced cell proliferation, as transformed from their usual spindle shape to a spherical shape, showing gaps between cells that indicated reduced adherence and proliferation. These findings suggest that the electric field effectively disrupts the cells’ ability to grow and multiply.
2. Apoptosis Induction: The electric field exposure induced apoptosis in the treated osteosarcoma cells. This was evidenced by a significant increase in the apoptotic index, with a notable rise in the expression levels of caspase-3 and caspase-9. The study found that these cells underwent apoptosis through an intrinsic pathway, which is characterized by the activation of mitochondrial-mediated events.
3. Gene Expression: Gene expression analysis revealed that p21, a key regulator of cell cycle progression, was significantly upregulated in the treated cells. Conversely, MDM2, a negative regulator of p53, was downregulated. This suggests that the electric field exposure led to cell cycle arrest by enhancing p21 activity, thereby inhibiting cell proliferation. The study also noted that p53 expression remained unchanged, indicating that the observed effects were mediated through a p53-independent pathway.
4. Caspase Activation: The study found that caspase-3 and caspase-9 were significantly upregulated in the treated cells, while caspase-8 levels remained unchanged. This selective activation of caspases is consistent with the intrinsic pathway of apoptosis, where caspase-9 plays a pivotal role in the mitochondrial pathway, ultimately leading to the activation of caspase-3, the primary executioner of apoptosis.

Clinical Implications

1. Non-invasive Cancer Therapy: The findings suggest that non-contact electric field exposure could serve as a non- invasive therapeutic option for osteosarcoma. Unlike traditional treatments such as chemotherapy and radiation, which often have severe side effects, electric field therapy is less likely to damage healthy cells. This makes it a promising alternative for cancer patients, particularly those who cannot tolerate or have not responded to conventional treatments.
2. Targeted Apoptosis Induction: The ability of electric field exposure to induce apoptosis through a p53-independent pathway is particularly significant. Many cancers, including osteosarcoma, often exhibit p53 mutations that render them resistant to therapies that rely on p53 activation. By targeting apoptosis through alternative pathways, electric field therapy could be effective even in p53-deficient tumors.
3. Potential for Combination Therapy: The study’s results indicate that electric field exposure could be used in combination with existing therapies to enhance their efficacy. For instance, it could be used as an adjuvant to chemotherapy or radiation to increase cell death and reduce the likelihood of tumor recurrence. This multimodal approach could improve treatment outcomes and survival rates in osteosarcoma patients.
4. Personalized Medicine: Given the variability in cancer cell responses to different treatments, the study’s findings could contribute to the development of personalized medicine strategies. By understanding the specific molecular pathways affected by electric field exposure, clinicians could tailor treatment plans to individual patients based on their tumor’s genetic profile and response to therapy.